# Viking Therapeutics, Inc.: filings

VKTX · Nasdaq · CIK 1607678 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vktx.md) · [Financials](/companies/vktx/financials.md) · [Filings](/companies/vktx/filings.md) · [Insiders](/companies/vktx/insiders.md)

## Reports and events: 182 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 191, 8-K 109, 144 50, 10-Q 35, CORRESP 26, SC 13G/A 22, 424B5 20, 3 16, SC 13G 15, UPLOAD 15, DEFA14A 13, 10-K 11, DEF 14A 11, S-1/A 11, S-8 11, S-8 POS 11, EFFECT 9, CT ORDER 5, S-1 5, 424B3 4, ARS 4, S-3 4, SCHEDULE 13G/A 4, 3/A 2, 424B4 2, 8-A12B 2, CERTNAS 2, FWP 2, S-1MEF 2, S-3ASR 2, 25-NSE 1, 305B2 1, 4/A 1, D 1, DEFR14A 1, DRS 1, PRE 14A 1, S-3/A 1, S-3MEF 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-28 | 17:27 ET | [8-K](/filings/0001193125-26-405580.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-405580 |
| 2026-09-22 | 07:06 ET | [8-K](/filings/0001193125-26-397219.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-397219 |
| 2026-07-29 | 17:15 ET | [10-Q](/filings/0001193125-26-324219.md) | Quarterly report, period 2026-06-30 | 0001193125-26-324219 |
| 2026-07-29 | 16:05 ET | [8-K](/filings/0001193125-26-323652.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-323652 |
| 2026-05-26 | 16:48 ET | [8-K](/filings/0001193125-26-239535.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-239535 |
| 2026-04-30 | 21:50 ET | [10-Q](/filings/0001193125-26-193315.md) | Quarterly report, period 2026-03-31 | 0001193125-26-193315 |
| 2026-04-29 | 16:05 ET | [8-K](/filings/0001193125-26-191487.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-191487 |
| 2026-04-01 | 16:14 ET | [DEF 14A](/filings/0001193125-26-137915.md) | Proxy statement, period 2026-05-19 | 0001193125-26-137915 |
| 2026-02-11 | 17:25 ET | [10-K](/filings/0001193125-26-046876.md) | Annual report, period 2025-12-31 | 0001193125-26-046876 |
| 2026-02-11 | 16:06 ET | [8-K](/filings/0001193125-26-046536.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-046536 |
| 2025-10-23 | 17:35 ET | [10-Q](/filings/0001193125-25-247059.md) | Quarterly report, period 2025-09-30 | 0001193125-25-247059 |
| 2025-10-22 | 16:10 ET | [8-K](/filings/0001193125-25-246775.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-246775 |
| 2025-08-19 | 07:09 ET | [8-K](/filings/0001607678-25-000003.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001607678-25-000003 |
| 2025-07-23 | 17:01 ET | [10-Q](/filings/0000950170-25-097950.md) | Quarterly report, period 2025-06-30 | 0000950170-25-097950 |
| 2025-07-23 | 16:05 ET | [8-K](/filings/0000950170-25-097885.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-097885 |
| 2025-05-27 | 17:20 ET | [8-K](/filings/0000950170-25-077865.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-077865 |
| 2025-04-24 | 16:37 ET | [10-Q](/filings/0000950170-25-058129.md) | Quarterly report, period 2025-03-31 | 0000950170-25-058129 |
| 2025-04-23 | 16:05 ET | [8-K](/filings/0000950170-25-057337.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-057337 |
| 2025-04-23 | 16:01 ET | [8-K](/filings/0000950170-25-057323.md) | 4.01 Change of auditor; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-057323 |
| 2025-04-08 | 17:03 ET | [DEF 14A](/filings/0000950170-25-052162.md) | Proxy statement, period 2025-05-20 | 0000950170-25-052162 |
| 2025-03-11 | 07:05 ET | [8-K](/filings/0000950170-25-036820.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-036820 |
| 2025-02-26 | 16:32 ET | [10-K](/filings/0000950170-25-027824.md) | Annual report, period 2024-12-31 | 0000950170-25-027824 |
| 2025-02-05 | 16:07 ET | [8-K](/filings/0000950170-25-014464.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-014464 |
| 2024-11-04 | 06:31 ET | [8-K](/filings/0000950170-24-120267.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-120267 |
| 2024-10-23 | 17:00 ET | [10-Q](/filings/0000950170-24-116708.md) | Quarterly report, period 2024-09-30 | 0000950170-24-116708 |
| 2024-10-23 | 16:09 ET | [8-K](/filings/0000950170-24-116642.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-116642 |
| 2024-07-24 | 17:00 ET | [10-Q](/filings/0000950170-24-086111.md) | Quarterly report, period 2024-06-30 | 0000950170-24-086111 |
| 2024-07-24 | 16:10 ET | [8-K](/filings/0000950170-24-086039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-086039 |
| 2024-06-04 | 07:10 ET | [8-K](/filings/0000950170-24-068297.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-068297 |
| 2024-05-23 | 19:54 ET | [8-K](/filings/0000950170-24-063707.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-063707 |
| 2024-04-25 | 20:42 ET | [10-Q](/filings/0000950170-24-047833.md) | Quarterly report, period 2024-03-31 | 0000950170-24-047833 |
| 2024-04-24 | 16:05 ET | [8-K](/filings/0000950170-24-047567.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-047567 |
| 2024-04-05 | 16:05 ET | [DEF 14A](/filings/0000950170-24-042251.md) | Proxy statement, period 2024-05-21 | 0000950170-24-042251 |
| 2024-03-26 | 07:08 ET | [8-K](/filings/0000950170-24-036151.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-036151 |
| 2024-03-04 | 16:52 ET | [8-K](/filings/0000950170-24-024878.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-024878 |
| 2024-03-01 | 16:05 ET | [8-K](/filings/0000950170-24-023838.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-023838 |
| 2024-02-27 | 07:04 ET | [8-K](/filings/0000950170-24-020616.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-020616 |
| 2024-02-07 | 17:24 ET | [10-K](/filings/0000950170-24-012322.md) | Annual report, period 2023-12-31 | 0000950170-24-012322 |
| 2024-02-07 | 16:09 ET | [8-K](/filings/0000950170-24-012199.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-012199 |
| 2023-10-25 | 17:05 ET | [10-Q](/filings/0000950170-23-055259.md) | Quarterly report, period 2023-09-30 | 0000950170-23-055259 |
| 2023-10-25 | 16:24 ET | [8-K](/filings/0000950170-23-055209.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-055209 |
| 2023-07-26 | 16:46 ET | [10-Q](/filings/0000950170-23-034773.md) | Quarterly report, period 2023-06-30 | 0000950170-23-034773 |
| 2023-07-26 | 16:23 ET | [8-K](/filings/0000950170-23-034741.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-034741 |
| 2023-06-14 | 16:23 ET | [8-K](/filings/0000950170-23-027965.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-23-027965 |
| 2023-05-11 | 17:00 ET | [8-K](/filings/0000950170-23-021359.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-23-021359 |
| 2023-05-01 | 16:01 ET | [DEF 14A](/filings/0000950170-23-016221.md) | Proxy statement | 0000950170-23-016221 |
| 2023-04-26 | 17:01 ET | [10-Q](/filings/0000950170-23-014883.md) | Quarterly report, period 2023-03-31 | 0000950170-23-014883 |
| 2023-04-26 | 16:06 ET | [8-K](/filings/0000950170-23-014788.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-014788 |
| 2023-04-03 | 17:17 ET | [8-K](/filings/0000950170-23-011636.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-011636 |
| 2023-03-31 | 17:27 ET | [8-K](/filings/0000950170-23-011443.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-011443 |

Page 1 of 4. [Older](/companies/vktx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.